Pharmaceutical firm tevapharmeurope said there are unresolved issues around medicine supplies and the protocol 💊 Brexit
Teva says this removed the "most onerous regulatory burdens arising from the protocol" and allowed it to continue supplying medicines to NI without additional complexities.Centralised Procedure product licencesIt says that in order to continue to supply products approved via the CP route in NI, an EU authorisation is required, so a company needs to have two different product licences, one covering GB and one covering NI.
The PAGB says a way needs to found to ensure medicines licenced via the CP route can be sold in both GB and NI as a single pack, without divergence in the licences behind them.Meanwhile, concerns have also been raised about how the government's replacement plan for the protocol would work in respect of medicines.
Teva said that "in theory" it could be supportive of a dual regulatory regime as it should allow UK-wide licencing.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
NI Protocol: Economic output may grow but prices could be higherAnalysis suggests the NI Protocol could see the output of the Northern Ireland economy increase but leave consumers facing higher prices
Read more »
NI Protocol: Businesses question government's plansBusinesses have asked the UK government dozens of questions about how the replacement for the Northern Ireland Protocol will work in practice Brexit
Read more »
NI Protocol: UK plays down imminent breakthroughUK Foreign Secretary JamesCleverly has played down expectations of an imminent breakthrough in negotiations over the Northern Ireland Protocol
Read more »
Prospective evaluation of smartwatch-enabled detection of left ventricular dysfunction - Nature MedicineIn this proof-of-concept prospective study, single-lead electrocardiograms obtained by smartwatches were able to identify individuals with left ventricular dysfunction, potentially serving as an early warning system for heart failure.
Read more »
Behind the Scenes of the Oncology & Precision Medicine Conferences 2022During the conference, we caught up with some of the speakers to learn more about their work, what they were presenting, and their thoughts about the future of Oncology and Precision Medicine.
Read more »
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms | NEJMMedicine and Society from The New England Journal of Medicine — Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms
Read more »